Cibc World Market Inc. Infla Rx N.V. Transaction History
Cibc World Market Inc.
- $47.5 Billion
- Q2 2025
A detailed history of Cibc World Market Inc. transactions in Infla Rx N.V. stock. As of the latest transaction made, Cibc World Market Inc. holds 25,000 shares of IFRX stock, worth $36,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$36,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IFRX
# of Institutions
30Shares Held
17.3MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$9.34 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$3.56 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$2.84 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$2.36 Million0.13% of portfolio
-
Woodline Partners LP San Francisco, CA751KShares$1.08 Million0.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $63.7M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...